| Sep 24 |
Capricor (CAPR) Surges 18.2%: Is This an Indication of Further Gains?
|
| Sep 15 |
MacroGenics Announces Updated Efficacy & Safety Data from TAMARACK Phase 2 Study of Vobra Duo in mCRPC Patients at ESMO Congress 2024
|
| Sep 13 |
Do Options Traders Know Something About MacroGenics (MGNX) Stock We Don't?
|
| Sep 8 |
MacroGenics Announces TAMARACK Phase 2 Data Presentation at ESMO Congress 2024
|
| Aug 10 |
MacroGenics Faces Uncertainty After Vobra Duo Setback
|
| Aug 9 |
MacroGenics, Inc. (NASDAQ:MGNX) Just Reported And Analysts Have Been Cutting Their Estimates
|
| Aug 7 |
How to Boost Your Portfolio with Top Medical Stocks Set to Beat Earnings
|
| Aug 7 |
Compared to Estimates, MacroGenics (MGNX) Q2 Earnings: A Look at Key Metrics
|
| Aug 6 |
MacroGenics (MGNX) Reports Q2 Loss, Lags Revenue Estimates
|
| Aug 6 |
MacroGenics GAAP EPS of -$0.89 misses by $0.30, revenue of $10.79M misses by $10.14M
|
